Masahiro Shibata

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer.

Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer.

Journal: The American journal of pathology

Published: July 23, 2025

Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs.

Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs.

Journal: Cancers

Published: June 04, 2025

ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer.

ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: February 24, 2025

Identification of peripheral blood test parameters predicting the response to palbociclib and endocrine therapy for metastatic breast cancer: a retrospective study in a single institution.

Identification of peripheral blood test parameters predicting the response to palbociclib and endocrine therapy for metastatic breast cancer: a retrospective study in a single institution.

Journal: Surgery today

Published: March 18, 2024

Adenylate cyclase 9 expression level is associated with hormone receptor-positive breast cancer and predicts patient prognosis.

Adenylate cyclase 9 expression level is associated with hormone receptor-positive breast cancer and predicts patient prognosis.

Journal: Nagoya journal of medical science

Published: January 15, 2024

Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors.

Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors.

Journal: Journal of bone and mineral metabolism

Published: December 01, 2022

Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer.

Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: September 17, 2021

Authors' Reply: Development of a Rapid Intraoperative Point-of-Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections.

Authors' Reply: Development of a Rapid Intraoperative Point-of-Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections.

Journal: World journal of surgery

Published: August 17, 2021

Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.

Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.

Journal: Oncology reports

Published: April 02, 2021

Development of a Rapid Intraoperative Point-of-Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections.

Development of a Rapid Intraoperative Point-of-Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections.

Journal: World journal of surgery

Published: March 02, 2021

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.

Journal: Nagoya journal of medical science

Published: November 16, 2020

Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.

Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.

Journal: Nagoya journal of medical science

Published: November 02, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026